Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@biotech_cash Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1578670727359856640.png) @biotech_cash Cash&BIO💸🧪🧬

Cash&BIO💸🧪🧬 posts on X about $allr, $25b, $1b, cape town the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1578670727359856640/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1578670727359856640/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXX +23%

### Mentions: X [#](/creator/twitter::1578670727359856640/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1578670727359856640/c:line/m:posts_active.svg)

- X Month XX -XX%
- X Months XX -XX%
- X Year XXX +20%

### Followers: XXX [#](/creator/twitter::1578670727359856640/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1578670727359856640/c:line/m:followers.svg)

- X Week XXX +1.30%
- X Month XXX +0.26%
- X Months XXX +25%
- X Year XXX +22%

### CreatorRank: undefined [#](/creator/twitter::1578670727359856640/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1578670727359856640/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1578670727359856640/influence)
---

**Social category influence**
[stocks](/list/stocks)  [travel destinations](/list/travel-destinations)  [countries](/list/countries)  [finance](/list/finance) 

**Social topic influence**
[$allr](/topic/$allr) #4, [$25b](/topic/$25b), [$1b](/topic/$1b), [cape town](/topic/cape-town), [south africa](/topic/south-africa), [$sprb](/topic/$sprb)
### Top Social Posts [#](/creator/twitter::1578670727359856640/posts)
---
Top posts by engagements in the last XX hours

"Potential partner deal AstraZeneca Leader in PARP space with Lynparza (olaparib $2.5B+ annual sales in ovarian/breast cancers). Strong gyno-oncology focus; recent $1B+ investments in precision oncology. Stenoparib could complement as a low-myelotoxicity option for resistant patients. $ALLR 👀👀💥💥"  
[X Link](https://x.com/biotech_cash/status/1981044400458448897) [@biotech_cash](/creator/x/biotech_cash) 2025-10-22T17:06Z XXX followers, XXX engagements


"$ALLR IGCS 2025 Annual Global Meeting (International Gynecologic Cancer Society) scheduled for November XX 2025 in Cape Town South Africa at the Century City Conference Centre. This event features cutting-edge research workshops and sessions on ovarian endometrial cervical and other gynecologic cancers aimed at clinicians researchers and global experts"  
[X Link](https://x.com/biotech_cash/status/1981083241109959148) [@biotech_cash](/creator/x/biotech_cash) 2025-10-22T19:40Z XXX followers, 1037 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@biotech_cash Avatar @biotech_cash Cash&BIO💸🧪🧬

Cash&BIO💸🧪🧬 posts on X about $allr, $25b, $1b, cape town the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXX -XX%
  • X Months XXXXXX -XX%
  • X Year XXXXXX +23%

Mentions: X #

Mentions Line Chart

  • X Month XX -XX%
  • X Months XX -XX%
  • X Year XXX +20%

Followers: XXX #

Followers Line Chart

  • X Week XXX +1.30%
  • X Month XXX +0.26%
  • X Months XXX +25%
  • X Year XXX +22%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #

Social category influence stocks travel destinations countries finance

Social topic influence $allr #4, $25b, $1b, cape town, south africa, $sprb

Top Social Posts #

Top posts by engagements in the last XX hours

"Potential partner deal AstraZeneca Leader in PARP space with Lynparza (olaparib $2.5B+ annual sales in ovarian/breast cancers). Strong gyno-oncology focus; recent $1B+ investments in precision oncology. Stenoparib could complement as a low-myelotoxicity option for resistant patients. $ALLR 👀👀💥💥"
X Link @biotech_cash 2025-10-22T17:06Z XXX followers, XXX engagements

"$ALLR IGCS 2025 Annual Global Meeting (International Gynecologic Cancer Society) scheduled for November XX 2025 in Cape Town South Africa at the Century City Conference Centre. This event features cutting-edge research workshops and sessions on ovarian endometrial cervical and other gynecologic cancers aimed at clinicians researchers and global experts"
X Link @biotech_cash 2025-10-22T19:40Z XXX followers, 1037 engagements

@biotech_cash
/creator/twitter::biotech_cash